Thyrotoxicosis as a Risk Factor for Pulmonary Arterial Hypertension
- Lewis J. Rubin, MD; and
- David B. Badesch, MD
- Form the University of California, San Diego, La Jolla, CA 92093, and the University of Colorado Health Sciences Center, Denver, CO 80262.
IN RESPONSE:
We agree with Drs. Ma and Chow that there is some justification for screening patients with PAH for thyroid dysfunction. We were among the first to make the observation that thyroid abnormalities might occur with increased frequency in …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
